MARKETAXESS HOLDINGS INC Stock Compensation Disclosure
11. Stock-Based Compensation Plans
The Company maintains the 2020 Plan which provides for the grant of Full Value Awards, stock options and other stock-based awards as incentives to encourage employees, consultants and non-employee directors to participate in the long-term success of the Company. As of December 31, 2025, there were 2,443,643 shares available for grant under the 2020 Plan.
Total stock-based compensation expense was as follows:
|
Year Ended December 31, |
|
||||||||||||
|
2025 |
|
|
2024 |
|
|
2023 |
|
||||||
|
(In thousands) |
|
||||||||||||
Employees |
|
|
|
|
|
|
|
|
|
|
|
|||
Full Value Awards |
$ |
|
27,195 |
|
|
$ |
|
27,607 |
|
|
$ |
|
24,205 |
|
Stock options |
|
|
1,053 |
|
|
|
|
1,728 |
|
|
|
|
3,592 |
|
Total employees |
|
|
28,248 |
|
|
|
|
29,335 |
|
|
|
|
27,797 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Non-employee directors |
|
|
|
|
|
|
|
|
|
|
|
|||
Restricted stock and restricted stock units |
|
|
3,883 |
|
|
|
|
1,512 |
|
|
|
|
1,393 |
|
Stock options |
|
|
537 |
|
|
|
|
— |
|
|
|
|
— |
|
Total non-employee directors and consultants |
|
|
4,420 |
|
|
|
|
1,512 |
|
|
|
|
1,393 |
|
Total stock-based compensation |
$ |
|
32,668 |
|
|
$ |
|
30,847 |
|
|
$ |
|
29,190 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
The Company records stock-based compensation expense for employees in employee compensation and benefits and for non-employee directors in general and administrative expenses in the Consolidated Statements of Operations. Total stock-based compensation for employees includes $1.8 million, $1.2 million and $0.9 million of capitalized software development costs for the years ended December 31, 2025, 2024 and 2023, respectively.
Stock Options
The exercise price of each option granted is equal to the market price of the Company’s common stock on the date of grant. Generally, option grants have provided for vesting over a three-year period. Options generally expire in six years from the date of grant. The fair value of each option award is estimated on the date of grant using the Black-Scholes option-pricing model. The determination of fair value of share-based payment awards on the date of grant using an option-pricing model is affected by the Company’s stock price as well as assumptions regarding a number of complex and subjective variables, including the expected stock price volatility over the term of the awards, the risk-free interest rate, the expected dividend yield rate and the expected term. Expected volatilities are based on historical volatility of the Company’s stock. The risk-free interest rate is based on U.S. Treasury securities with a maturity value approximating the expected term of the option. The dividend yield rate is based on the expected annual dividends to be paid divided by the expected stock price. The expected term represents the period of time that options granted are expected to be outstanding based on actual and projected employee stock option exercise behavior.
The weighted-average fair value for options granted during the years ended December 31, 2025, 2024 and 2023 were $67.20, $77.16 and $123.47, respectively. The following table represents the assumptions used for the Black-Scholes option-pricing model to determine the per share weighted-average fair value for options granted:
|
Year Ended December 31, |
|
|||||||||
|
2025 |
|
|
2024 |
|
|
2023 |
|
|||
Expected life (years) |
|
5.0 |
|
|
|
4.7 |
|
|
|
5.0 |
|
Risk-free interest rate |
|
4.2 |
% |
|
|
4.0 |
% |
|
|
3.6 |
% |
Expected volatility |
|
38.2 |
% |
|
|
39.2 |
% |
|
|
35.8 |
% |
Expected dividend yield |
|
1.5 |
% |
|
|
1.3 |
% |
|
|
0.8 |
% |
|
|
|
|
|
|
|
|
|
|||
The following table reports stock option activity during the years ended December 31, 2025, 2024 and 2023 and the intrinsic value as of December 31, 2025:
|
Number |
|
|
Weighted-Average Exercise Price ($) |
|
|
Remaining |
|
|
Intrinsic Value ($) |
|
||||
|
|
|
|
|
|
|
|
|
|
(In thousands) |
|
||||
Outstanding at December 31, 2022 |
|
306,253 |
|
|
$ |
290.65 |
|
|
|
|
|
|
|
||
Granted |
|
13,908 |
|
|
|
358.53 |
|
|
|
|
|
|
|
||
Canceled or forfeited |
|
(551 |
) |
|
|
382.12 |
|
|
|
|
|
|
|
||
Exercised |
|
(5,653 |
) |
|
|
166.34 |
|
|
|
|
|
|
|
||
Outstanding at December 31, 2023 |
|
313,957 |
|
|
|
295.74 |
|
|
|
|
|
|
|
||
Granted |
|
20,793 |
|
|
|
220.50 |
|
|
|
|
|
|
|
||
Canceled or forfeited |
|
(229,478 |
) |
|
|
276.79 |
|
|
|
|
|
|
|
||
Exercised |
|
(22,044 |
) |
|
|
205.28 |
|
|
|
|
|
|
|
||
Outstanding at December 31, 2024 |
|
83,228 |
|
|
|
353.14 |
|
|
|
|
|
|
|
||
Granted |
|
20,606 |
|
|
|
193.49 |
|
|
|
|
|
|
|
||
Canceled or forfeited |
|
(740 |
) |
|
|
374.44 |
|
|
|
|
|
|
|
||
Exercised |
|
— |
|
|
|
— |
|
|
|
|
|
|
— |
|
|
Outstanding at December 31, 2025 |
|
103,094 |
|
|
|
321.08 |
|
|
|
3.2 |
|
|
|
— |
|
Exercisable at December 31, 2025 |
|
64,486 |
|
|
|
380.77 |
|
|
|
2.2 |
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
||||
The intrinsic value is the amount by which the closing price of the Company’s common stock on December 31, 2025 of $181.25 or the price on the day of exercise exceeds the exercise price of the stock options multiplied by the number of shares. As of December 31, 2025, there was $1.6 million of total unrecognized compensation cost related to unvested stock options. That cost is expected to be recognized over a weighted-average period of 1.5 years.
Service-Based Restricted Stock and Restricted Stock Unit Awards
Our annual compensation program includes share-based compensation awards as a component of certain employees’ total compensation. These awards generally vest ratably over a three-year period, subject to continued service to the Company. In addition, we grant share-based compensation awards in conjunction with certain new hires and for retention purposes. These awards generally vest over a three-year period. The Company also grants share-based compensation awards to its non-employee directors as part of such directors’ compensation. These awards generally vest on the earlier of the date of the Company’s next annual stockholders’ meeting or the one-year anniversary of the grant date, subject to continued service to the Company. Such share-based compensation awards are expensed over the requisite service period.
Annual Performance-based Performance Stock Unit Awards
The Company grants performance stock unit awards to certain executives and certain senior managers of the firm as a component of their total compensation and in conjunction with certain new hires and for retention purposes. Annual performance stock unit awards generally cliff-vest on the third anniversary of the grant date based on the certification of certain performance metrics and subject to the applicable employee’s continued service with the Company.
In February 2023, February 2024 and February 2025, annual performance stock units were granted with a three-year performance period that will vest based on the level of achievement by the Company of certain predetermined metrics, including pre-tax adjusted operating margin, U.S. credit market share and revenue growth excluding U.S. credit for the following three fiscal years, including the year of grant. The final awarded payout for the awards granted in 2023, 2024 and 2025 will range from zero to 200%. Subject to the grantee’s continued service, any performance stock unit award awarded to a participant will vest on the three-year anniversary of the grant date. Compensation expense for the three-year performance stock units is measured at the grant date and expensed over the requisite service period with performance target achievement assessed at the end of each reporting period.
Other Performance Stock Unit Awards
In March 2022, the Company’s Chief Information Officer received a one-time sign-on equity award consisting, in part, of a performance stock unit award with a target of 3,986 shares. The award vested on March 1, 2025 after certification of the performance criteria. Compensation expense for the Chief Information Officer award was measured at the grant date and was expensed over the requisite service period with performance target achievement assessed at the end of each reporting period.
In April 2023, in connection with his appointment to the position, the Company’s Chief Executive Officer received a one-time equity award consisting, in part, of a performance stock unit award with a target of 5,039 shares. The performance stock units vest 25% on each of the third and fourth anniversaries of the grant date and 50% on the fifth anniversary of the grant date, subject to certification of the performance criteria and his continued service through the respective vesting dates. Compensation expense for the Chief Executive Officer award was measured at the grant date and will be expensed over the requisite service period.
In June 2024, the Company’s Chief Financial Officer received a one-time sign-on equity award consisting, in part, of a performance stock unit award with a target of 1,797 shares. The award will vest on June 3, 2027 after certification of the performance criteria, subject to her continued service through such date. Compensation expense for the Chief Financial Officer award was measured at the grant date and will be expensed over the requisite service period with performance target achievement assessed at the end of each reporting period.
Performance Stock Unit Award Estimates
The following table reports the Company’s performance payout estimates for three-year performance period awards as of December 31, 2025, as well as the target and maximum share payouts for each award date granted:
Award Date |
|
Estimate |
|
|
Target |
|
|
Maximum |
|
|||
February 15, 2023 |
|
|
6,942 |
|
|
|
16,273 |
|
|
|
32,546 |
|
February 15, 2024 |
|
|
23,656 |
|
|
|
24,147 |
|
|
|
48,294 |
|
June 3, 2024 |
|
|
1,633 |
|
|
|
1,797 |
|
|
|
3,594 |
|
February 15, 2025 |
|
|
26,592 |
|
|
|
27,871 |
|
|
|
55,742 |
|
|
|
|
|
|
|
|
|
|
|
|||
Equity Grant Activity
The following table reports Full Value Awards activity during the years ended December 31, 2025, 2024 and 2023:
|
|
Number of Restricted Shares |
|
|
Weighted-Average Grant Date Fair Value ($) |
|
||
Outstanding at December 31, 2022 |
|
|
162,356 |
|
|
$ |
321.04 |
|
Granted |
|
|
90,242 |
|
|
|
328.17 |
|
Performance share pay-out |
|
|
12,145 |
|
|
|
360.90 |
|
Forfeited |
|
|
(5,272 |
) |
|
|
376.51 |
|
Vested |
|
|
(98,927 |
) |
|
|
288.73 |
|
Outstanding at December 31, 2023 |
|
|
160,544 |
|
|
|
346.15 |
|
Granted |
|
|
150,031 |
|
|
|
217.80 |
|
Performance share pay-out |
|
|
4,739 |
|
|
|
522.57 |
|
Forfeited |
|
|
(29,581 |
) |
|
|
255.35 |
|
Vested |
|
|
(85,932 |
) |
|
|
324.42 |
|
Outstanding at December 31, 2024 |
|
|
199,801 |
|
|
|
276.74 |
|
Granted |
|
|
203,579 |
|
|
|
194.20 |
|
Performance share pay-out |
|
|
9,812 |
|
|
|
350.94 |
|
Forfeited |
|
|
(30,645 |
) |
|
|
226.61 |
|
Vested |
|
|
(107,995 |
) |
|
|
278.22 |
|
Outstanding at December 31, 2025 |
|
|
274,552 |
|
|
|
223.20 |
|
|
|
|
|
|
|
|
||
As of December 31, 2025, there was $42.7 million of total unrecognized compensation cost related to Full Value Awards. That cost is expected to be recognized over a weighted-average period of 1.7 years.
Employee Stock Purchase Plan
The Company maintains the MarketAxess Holdings Inc. 2022 Employee Stock Purchase Plan (the “ESPP”) pursuant to which a total of 121,221 shares of the Company’s Common Stock will be made available for purchase by employees. During the year ended December 31, 2025, the Company issued 10,343 shares of common stock under the ESPP. As of December 31, 2025, there were 97,712 shares available for purchase under the ESPP.
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Feb 24, 2026 | Showing above |
| 2017 | Feb 21, 2018 | |
About Stock Compensation Disclosures
Stock-based compensation disclosures detail the equity awards granted to employees and executives — including stock options, restricted stock units (RSUs), and performance shares — along with the valuation methods and assumptions used to expense them. This section reveals the true cost of talent retention and the alignment between management incentives and shareholder interests.
Key signals: total unrecognized compensation expense and its expected recognition period signal future earnings headwinds from already-granted awards. For stock options, examine Black-Scholes assumptions — expected volatility, risk-free rate, and expected term — as understating any of these reduces reported compensation expense. Compare stock compensation expense as a percentage of revenue against peers to assess dilution cost. Watch vesting schedules for acceleration clauses tied to change-of-control events. Performance-based awards with undemanding targets may indicate weak governance. Add back stock compensation to operating cash flow to calculate a more conservative free cash flow figure.